Email Alert | RSS

Journal of Tuberculosis and Lung Disease ›› 2024, Vol. 5 ›› Issue (5): 398-403.doi: 10.19983/j.issn.2096-8493.2024105

• Interpretation of Standards • Previous Articles     Next Articles

Interpretation of the 2023 U.S. Preventive Clinical Services Guidelines Workgroup Statement of Recommendations for Screening Adults for Latent Tuberculosis Infection

Wu Xiucen, Chen Guihua()   

  1. Shool of Nursing, Chongqing Medical University, Chongqing 400016, China
  • Received:2024-06-24 Online:2024-10-20 Published:2024-10-14
  • Contact: Chen Guihua E-mail:300278@hospital.cqmu.edu.cn
  • Supported by:
    Chongqing Medical University Nursing Leap Plan(20240207)

Abstract:

Individuals with latent tuberculosis infection constitute a substantial reservoir of potential tuberculosis cases, contributing to ongoing transmission within populations and posing a significant threat to public health and human life. In 2016, the U.S. Preventive Services Task Force introduced guidelines for the screening and treatment of latent tuberculosis infection. However, these guidelines did not clearly define the specific populations that should be targeted by the recommended treatment protocols. Drawing on the latest research evidence, the 2023 U.S. Preventive Services Task Force revised its recommendations on the screening of latent tuberculosis infection in adults. This update seeks to elucidate the screening pathways for latent tuberculosis infection, identify the specific populations that would benefit from treatment regimens, and establish a clear framework for the clinical management of latent tuberculosis infection in adults. This article aims to interpret these updated recommendations and offer guidance for the screening of latent tuberculosis infection in adults within the context of China.

Key words: Mycobacterium tuberculosis, Adults, Infection, Guidelines

CLC Number: